Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease

Pediatric Blood and Cancer

Volumn 61, Issue 2, 2014, Pages 291-296

  Dampier, Carlton ^a   Ely, Beth ^b   Brodecki, Darcy ^b   Coleman, Camille ^c   Aertker, Leela ^d   Sendecki, Jocelyn Andrel ^e   Leiby, Benjamin ^e   Kesler, Karen ^d   Hyslop, Terry ^e   Stuart, Marie ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^d RHO INC   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Infants; Pain; Sickle cell disease

Indexed keywords

ARTICLE; CHILD; CHILD HOSPITALIZATION; DACTYLITIS; FEMALE; GENOTYPE; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; OBSERVATIONAL STUDY; ONSET AGE; PAIN; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SYMPTOM ASSESSMENT;

EID: 84890880064     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24796     Document Type: Article

References (21)

1. Stevens MC, Padwick M, Serjeant GR. Observations on the natural history of dactylitis in homozygous sickle cell disease. Clin Pediatr (Phila) 1981; 20:311-317.
2. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995; 86:776-783.
3. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet 2011; 377:1663-1672.
4. Bailey K, Morris JS, Thomas P, et al. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992; 67:517-520.
5. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342:83-89.
6. Quinn CT, Shull EP, Ahmad N, et al. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood 2007; 109:40-45.
7. Foucan L, Ekouevi D, Etienne-Julan M, et al. Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99). Paediatr Perinat Epidemiol 2006; 20:59-66.
8. Ely B, Dampier C, Gilday M, et al. Caregiver report of pain in infants and toddlers with sickle cell disease: Reliability and validity of a daily diary. J Pain 2002; 3:50-57.
9. Dampier C, Ely E, Brodecki D, et al. Home management of pain in sickle cell disease: A daily diary study in children and adolescents. J Pediatr Hematol Oncol 2002; 24:643-647.
10. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148:94-101.
11. Roeder K, Lynch K, Nagin D. Modeling uncertainty in latent class membership: A case study in criminology. J Am Stat Assoc 1999; 94:766-767.
12. Muthén LKaM. B.O. Mplus user's guide. Los Angeles, CA: Muthén & Muthén; 1998-2012.
13. Dampier C, Lieff S, LeBeau P, et al. Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium. Pediatr Blood Cancer 2010; 55:485-494.
14. Peters JW, Schouw R, Anand KJ, et al. Does neonatal surgery lead to increased pain sensitivity in later childhood? Pain 2005; 114:444-454.
15. Hermann C, Hohmeister J, Demirakca S, et al. Long-term alteration of pain sensitivity in school-aged children with early pain experiences. Pain 2006; 125:278-285.
16. Ely B, Coleman C. Recruitment and retention of children in longitudinal research. J Spec Pediatr Nurs 2007; 12:199-202.
17. Dampier C, Ely B, Brodecki D, et al. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain 2002; 3:461-470.
18. Dampier C, Setty BN, Eggleston B, et al. Vaso-occlusion in children with sickle cell disease: Clinical characteristics and biologic correlates. J Pediatr Hematol Oncol 2004; 26:785-790.
19. Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood 2012; 120:4304-4310.
20. Ballas SK, Bauserman RL, McCarthy WF, et al. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: Effect of sex, age, and geographical location. Am J Hematol 2010; 85:613-616.
21. Smith WR, Ballas SK, McCarthy WF, et al. The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients. Pain Med 2011; 12:697-705.